Association between chronological age and vascular function in adults with and without multiple sclerosis

Noah G DuBose1, Sydney R DeJonge1, Trevor B Martin1

  • 1Integrative Physiology Laboratory, College of Applied Health Sciences, University of Illinois at Chicago, Chicago, IL, USA; Department of Kinesiology and Nutrition, College of Applied Health Sciences, University of Illinois at Chicago, Chicago, IL, USA.

Abstract

Insights

Age significantly predicts vascular function in multiple sclerosis (MS) patients, impacting outcomes like cognition and fatigue. This highlights the need to study vascular aging throughout the MS lifespan.

Area of Science:

  • Cardiovascular Health
  • Neurology
  • Aging Research

Background:

  • Multiple sclerosis (MS) is linked to vascular comorbidities that worsen with age.
  • Vascular function (VF) impacts MS outcomes including cognition, fatigue, and disability.
  • The relationship between age and VF in MS is not well understood.

Purpose of the Study:

  • To compare vascular function (VF) between MS patients and controls.
  • To investigate age as a predictor of VF parameters in MS.
  • To assess carotid-femoral pulse wave velocity (PWV) and augmentation index (AIx75).

Main Methods:

  • Compared 129 MS patients and 51 controls on PWV and AIx75.
  • Utilized regression analysis to determine predictors of VF.
  • Controlled for factors like BMI, MAP, sex, EDSS, and disease duration.

Main Results:

  • MS patients had higher PWV (7.2 m/s) than controls (6.6 m/s); AIx75 did not differ.
  • Age significantly predicted PWV in MS patients after controlling for BMI and MAP (β = 0.256, p<0.01).
  • Age significantly predicted AIx75 in both MS patients (β = 0.371, p<0.01) and controls (β = 0.347, p<0.01) after relevant adjustments.

Conclusions:

  • Age is a significant predictor of vascular function in individuals with MS.
  • Future research should explore vascular aging across the lifespan in MS.
  • Understanding age-related VF changes is crucial for managing MS outcomes.

Related Concept Videos

Comprehensive Autopsy Program for Individuals with Multiple Sclerosis09:41

Comprehensive Autopsy Program for Individuals with Multiple Sclerosis

Multiple sclerosis is an inflammatory demyelinating disease with no cure. Analysis of brain tissue provides important clues to understanding the pathogenesis of the disease. Here we discuss the methodology and downstream analysis of MS brain tissue collected through a unique rapid autopsy program in operation at the Cleveland...
12.0K
The Multiple Sclerosis Performance Test (MSPT): An iPad-Based Disability Assessment Tool11:35

The Multiple Sclerosis Performance Test (MSPT): An iPad-Based Disability Assessment Tool

Precise measurement of neurological and neuropsychological impairment and disability in multiple sclerosis is challenging. We report methodologic details on a new test, the Multiple Sclerosis Performance Test (MSPT). This new approach to the objective of quantification of MS related disability provides a computer-based platform for precise, valid measurement of MS...
58.6K
Studying Age-dependent Genomic Instability using the S. cerevisiae Chronological Lifespan Model08:46

Studying Age-dependent Genomic Instability using the S. cerevisiae Chronological Lifespan Model

Here we describe a set of DNA mutation assays that can be combined with the yeast chronological life span model to study the genes/pathways that regulate or contribute to genomic DNA instability during...
16.0K
Quantifying Yeast Chronological Life Span by Outgrowth of Aged Cells12:24

Quantifying Yeast Chronological Life Span by Outgrowth of Aged Cells

Chronological aging in yeast refers to the loss of cell viability associated with time in stationary phase. Here we describe a high-throughput method for quantitatively determining yeast chronological life...
17.2K
A Protocol for the Use of Remotely-Supervised Transcranial Direct Current Stimulation (tDCS) in Multiple Sclerosis (MS)08:18

A Protocol for the Use of Remotely-Supervised Transcranial Direct Current Stimulation (tDCS) in Multiple Sclerosis (MS)

The goal of this pilot study is to describe a protocol for the remotely-supervised delivery of transcranial direct current stimulation (tDCS) so that the procedure maintains standards of in-clinic practice, including safety, reproducibility, and tolerability. The feasibility of this protocol was tested in participants with multiple sclerosis (MS).
18.1K
Measuring Progressive Neurological Disability in a Mouse Model of Multiple Sclerosis08:11

Measuring Progressive Neurological Disability in a Mouse Model of Multiple Sclerosis

An optimized testing protocol is presented in this paper for the Rotarod performance test, used for measuring progressive neurological disability in TMEV-infected mice.
11.5K